Skip to content
You are now leaving https://www.ionispharma.com to visit

Ionis reports first quarter 2019 financial results

Revenues more than doubled compared to 2018, resulting in net income of $84 million Nearly $300 million in revenues driven by $150 million license fee from Novartis and growing commercial revenues Conference call and webcast today, May 9, 2019, at 11:30 a.m. Eastern Time CARLSBAD, Calif.